INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO)

CUSIP: 45773H409

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+3,736,670
Put/Call ratio
106%
SEC-reported price per share
$13.88
Number of holders
83
Value change
+$53,680,856
Number of buys
77
Open additional details 1 more signal available
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
105,959,345

Security key

45773H409

Report period

Q1 2024

Institutions

83

Top holders

10

Ownership snapshot

Top reported holders of INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $10,080,691 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $10.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $10.08M
RENAISSANCE TECHNOLOGIES LLC $3.72M
Jong Joseph Kim $2.45M
BlackRock Finance, Inc. $2.01M
GSA CAPITAL PARTNERS LLP $1.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$10,080,691
19,766,062 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$3,722,000
7,297,379 shares
— 31 Dec 2023
Jong Joseph Kim
3/4/5
Chief Executive Officer, Director
—
mixed-class rows
$2,451,149
3,113,086 shares
mixed-class rows
— 11 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$2,005,608
3,932,564 shares
— 31 Dec 2023
GSA CAPITAL PARTNERS LLP
13F
Company
13F
—
denominator unverified
$1,936,000
3,796,529 shares
— 31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,464,759
2,871,445 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
83
Shares
4,044,287
Rows available
83
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
83
Q1 2024 holders
83
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .